FDA Approves HPV Test To Identify Women At Risk For Cervical Cancer

OncLive (4/21, Broderick) reports the FDA approved Roche’s cobas HPV test “for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer.”